Maria Dalamaga

发表

Sepsis-Associated Acute Kidney Injury: Where Are We Now?

N. Vallianou, D. Kounatidis, T. Stratigou, 2024, Medicina.

Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD

H. Randeva, K. Chatha, Lukasz Lagojda, 2024, Current obesity reports.

Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential

N. Vallianou, D. Kounatidis, I. Karampela, 2024, Biomolecules.

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?

N. Vallianou, D. Kounatidis, A. Poulaki, 2024, International journal of molecular sciences.

NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics

N. Vallianou, E. Geladari, D. Kounatidis, 2024, Biomedicines.

The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies

I. Mourouzis, N. Vallianou, D. Kounatidis, 2024, Metabolites.

25-hydroxyvitamin D and parathyroid hormone in new onset sepsis: A prospective study in critically ill patients

N. Vallianou, D. Kounatidis, T. Stratigou, 2024, Metabolism open.

The Kidney in Obesity: Current Evidence, Perspectives and Controversies.

N. Vallianou, D. Kounatidis, T. Stratigou, 2024, Current obesity reports.

The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence

N. Vallianou, E. Geladari, D. Kounatidis, 2024, Current nutrition reports.

Diet patterns, gut microbiota and metabolic disorders: Perspectives and challenges

Maria Dalamaga, Christina Tsigalou, 2024, Metabolism Open.